Published May 29, 2012
A new report says that as many as one third of the antimalarial drugs sold in south Asian and sub Saharan African countries are counterfeit - or of such poor quality as to be ineffective. VOA's Vidushi Sinha reports that experts say this not only jeopardizes the progress made against malaria in the past decade - but also is speeding the emergence of drug resistance in the malaria parasite.